Clinical Trial Update: Sitagliptin Comparative Study in Patients With Type 2 Diabetes (0431-049) [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 comparative trial of sitagliptin in patients with Type 2 diabetes. Results from the study have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Sitagliptin (sitagliptin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2009-08-11